RT Journal Article
SR Electronic
T1 Data-Driven Patterns in Protective Effects of Ibuprofen and Ketorolac on Hospitalized Covid-19 Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.15.21258991
DO 10.1101/2021.06.15.21258991
A1 Lengerich, Benjamin J.
A1 Caruana, Rich
A1 Aphinayanaphongs, Yin
YR 2021
UL http://medrxiv.org/content/early/2021/06/22/2021.06.15.21258991.abstract
AB The impact of nonsteroidal anti-inflammatory drugs (NSAIDs) on patients with Covid-19 has been unclear. A major reason for this uncertainty is the confounding between treatments, patient comorbidities, and illness severity. Here, we perform an observational analysis of over 3000 patients hospitalized for Covid-19 in a New York hospital system to identify the relationship between in-patient treatment with Ibuprofen or Ketorolac and mortality. Our analysis finds evidence consitent with a protective effect for Ibuprofen and Ketorolac, with evidence stronger for a protective effect of Ketorolac than for a protective effect of Ibuprofen.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The NYU Langone Health Institutional Review Board (IRB) determined that the proposed activity is not research involving human subjects. IRB review and approval is not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data include anonymized medical records, which are not publicly available.